Skip to main content
OpenTrials

Clinical trial condition

Metastatic Pancreatic Adenocarcinoma

Explore clinical trials studying Metastatic Pancreatic Adenocarcinoma. Study availability and eligibility vary by location and protocol.

80 public trials 12 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Pancreatic Adenocarcinoma trial results

Recruiting

Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer

NCT06576115

Conditions
Metastatic Pancreatic Adenocarcinoma
Locations
  • Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
  • Karmanos Cancer Institute at McLaren Greater Lansing Lansing, Michigan, United States
View Trial Details
Completed

FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer

NCT02890355

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +8 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 783 locations
View Trial Details

Related conditions